Repligen Corporation to Present at 41st Annual J.P. Morgan Healthcare ConferenceGlobeNewsWire • 01/03/23
Repligen (RGEN) Up 4.3% Since Last Earnings Report: Can It Continue?Zacks Investment Research • 12/01/22
Repligen Reports Third Quarter 2022 Financial Results and Updates Full Year 2022 Financial GuidanceGlobeNewsWire • 11/01/22
Repligen Extends and Expands Long-Term Supply Agreement with Purolite for Affinity LigandsGlobeNewsWire • 11/01/22
4 under-the-radar stock picks from a five-star fund manager who sees rewards that are worth the risksMarket Watch • 10/06/22